Is Treace Medical Stock a Good Investment?
Treace Medical Investment Advice | TMCI |
- Examine Treace Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Treace Medical's leadership team and their track record. Good management can help Treace Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Treace Medical's business and its evolving consumer preferences.
- Compare Treace Medical's performance and market position to its competitors. Analyze how Treace Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Treace Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Treace Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Treace Medical Concepts stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Treace Medical Concepts is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Good | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Treace Medical Stock
Researching Treace Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 25.0% of the company outstanding shares are owned by corporate insiders. The book value of Treace Medical was at this time reported as 1.69. The company recorded a loss per share of 0.99. Treace Medical Concepts had not issued any dividends in recent years.
To determine if Treace Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Treace Medical's research are outlined below:
| Treace Medical is way too risky over 90 days horizon | |
| Treace Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 187.12 M. Net Loss for the year was (49.53 M) with profit before overhead, payroll, taxes, and interest of 163.53 M. | |
| Treace Medical Concepts currently holds about 101.53 M in cash with (34.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Treace Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 65.0% of the company shares are owned by institutional investors | |
| Latest headline from seekingalpha.com: Treace Medical Concepts reports Q4 preliminary revenue of 68.4M - 68.8M |
Treace Medical Quarterly Liabilities And Stockholders Equity |
|
Treace Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Treace Medical Concepts. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Treace Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Treace Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Treace Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-02-27 | 2023-12-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2021-05-25 | 2021-03-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2021-08-05 | 2021-06-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2023-08-08 | 2023-06-30 | -0.24 | -0.2 | 0.04 | 16 | ||
2022-05-05 | 2022-03-31 | -0.2 | -0.16 | 0.04 | 20 | ||
2023-03-07 | 2022-12-31 | -0.14 | -0.08 | 0.06 | 42 | ||
2022-11-08 | 2022-09-30 | -0.29 | -0.22 | 0.07 | 24 | ||
2022-08-09 | 2022-06-30 | -0.2 | -0.31 | -0.11 | 55 |
Treace Medical Target Price Consensus
Treace target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Treace Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Buy |
Most Treace analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Treace stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Treace Medical Concepts, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTreace Medical Target Price Projection
Treace Medical's current and average target prices are 8.71 and 9.05, respectively. The current price of Treace Medical is the price at which Treace Medical Concepts is currently trading. On the other hand, Treace Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Treace Medical Market Quote on 17th of January 2025
Target Price
Analyst Consensus On Treace Medical Target Price
Treace Medical Analyst Ratings
Treace Medical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Treace Medical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Treace Medical's financials, market performance, and future outlook by experienced professionals. Treace Medical's historical ratings below, therefore, can serve as a valuable tool for investors.Know Treace Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Treace Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Treace Medical Concepts backward and forwards among themselves. Treace Medical's institutional investor refers to the entity that pools money to purchase Treace Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-09-30 | 997.5 K | Soleus Capital Management, L.p. | 2024-09-30 | 887.9 K | Kent Lake Capital Llc | 2024-06-30 | 750 K | Goldman Sachs Group Inc | 2024-09-30 | 665.2 K | Millennium Management Llc | 2024-09-30 | 554.5 K | Kornitzer Capital Management Inc | 2024-09-30 | 526.9 K | Gagnon Advisors, Llc | 2024-09-30 | 489.9 K | Northern Trust Corp | 2024-09-30 | 458.2 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 426.7 K | Armistice Capital, Llc | 2024-09-30 | 6.2 M | Blackrock Inc | 2024-09-30 | 4.2 M |
Treace Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 513.95 M.Market Cap |
|
Treace Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.23) | (0.24) | |
| Return On Equity | (0.32) | (0.34) |
Determining Treace Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Treace Medical is a good buy. For example, gross profit margin measures Treace Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Treace Medical's profitability and make more informed investment decisions.
Evaluate Treace Medical's management efficiency
Treace Medical Concepts has return on total asset (ROA) of (0.1713) % which means that it has lost $0.1713 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5069) %, meaning that it created substantial loss on money invested by shareholders. Treace Medical's management efficiency ratios could be used to measure how well Treace Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.26. The current Return On Capital Employed is estimated to decrease to -0.3. As of now, Treace Medical's Other Current Assets are increasing as compared to previous years. The Treace Medical's current Debt To Assets is estimated to increase to 0.51, while Net Tangible Assets are projected to decrease to under 39 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.04 | 2.14 | |
| Tangible Book Value Per Share | 1.72 | 1.80 | |
| Enterprise Value Over EBITDA | (19.22) | (18.26) | |
| Price Book Value Ratio | 6.47 | 6.15 | |
| Enterprise Value Multiple | (19.22) | (18.26) | |
| Price Fair Value | 6.47 | 6.15 | |
| Enterprise Value | 958.2 M | 1.3 B |
Treace Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Beta 0.24 |
Basic technical analysis of Treace Stock
As of the 17th of January 2025, Treace Medical has the Risk Adjusted Performance of 0.1289, semi deviation of 2.37, and Coefficient Of Variation of 694.96. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Treace Medical Concepts, as well as the relationship between them.Treace Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Treace Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Treace Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Treace Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Treace Medical's Outstanding Corporate Bonds
Treace Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Treace Medical Concepts uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Treace bonds can be classified according to their maturity, which is the date when Treace Medical Concepts has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| International Game Technology Corp BondUS460599AD57 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Treace Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Treace Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1289 | |||
| Market Risk Adjusted Performance | 0.5021 | |||
| Mean Deviation | 3.39 | |||
| Semi Deviation | 2.37 | |||
| Downside Deviation | 2.71 | |||
| Coefficient Of Variation | 694.96 | |||
| Standard Deviation | 5.76 | |||
| Variance | 33.16 | |||
| Information Ratio | 0.1428 | |||
| Jensen Alpha | 0.8244 | |||
| Total Risk Alpha | 0.8426 | |||
| Sortino Ratio | 0.3032 | |||
| Treynor Ratio | 0.4921 | |||
| Maximum Drawdown | 42.04 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 8.14 | |||
| Downside Variance | 7.35 | |||
| Semi Variance | 5.61 | |||
| Expected Short fall | (4.91) | |||
| Skewness | 3.65 | |||
| Kurtosis | 19.16 |
| Risk Adjusted Performance | 0.1289 | |||
| Market Risk Adjusted Performance | 0.5021 | |||
| Mean Deviation | 3.39 | |||
| Semi Deviation | 2.37 | |||
| Downside Deviation | 2.71 | |||
| Coefficient Of Variation | 694.96 | |||
| Standard Deviation | 5.76 | |||
| Variance | 33.16 | |||
| Information Ratio | 0.1428 | |||
| Jensen Alpha | 0.8244 | |||
| Total Risk Alpha | 0.8426 | |||
| Sortino Ratio | 0.3032 | |||
| Treynor Ratio | 0.4921 | |||
| Maximum Drawdown | 42.04 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 8.14 | |||
| Downside Variance | 7.35 | |||
| Semi Variance | 5.61 | |||
| Expected Short fall | (4.91) | |||
| Skewness | 3.65 | |||
| Kurtosis | 19.16 |
Consider Treace Medical's intraday indicators
Treace Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Treace Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 27864.49 | |||
| Daily Balance Of Power | 0.7302 | |||
| Rate Of Daily Change | 1.06 | |||
| Day Median Price | 8.55 | |||
| Day Typical Price | 8.6 | |||
| Price Action Indicator | 0.4 | |||
| Period Momentum Indicator | 0.46 |
Treace Medical Corporate Filings
F4 | 14th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 5th of December 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Treace Stock media impact
Far too much social signal, news, headlines, and media speculation about Treace Medical that are available to investors today. That information is available publicly through Treace media outlets and privately through word of mouth or via Treace internal channels. However, regardless of the origin, that massive amount of Treace data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Treace Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Treace Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Treace Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Treace Medical alpha.
Treace Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Treace Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Treace Medical Corporate Management
| Shana Zink | Senior Reimbursement | Profile | |
| Julie Dewey | Chief Officer | Profile | |
| Scot JD | Chief Secretary | Profile | |
| Thomas Timbie | Independent Director | Profile | |
| John Treace | Founder CEO | Profile | |
| Sean Scanlan | Chief Officer | Profile | |
| Nathan Minnich | Senior Marketing | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets | Return On Equity |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Treace Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.